Klearchos Papas, a University of Arizona professor in the department of surgery, is leading a team to develop a new way to treat Type 1 diabetes. The treatment would release insulin into a person when an oxygen-enhanced implantable device senses their glucose level is too low.
The device would also remove the need for immunosuppression, which current treatments require. In immunosuppression, the patient’s immune system is permanently suppressed to allow for outside cells to be introduced, which can lead to increased risk of infection.
Papas has worked for the UA since 2011 and is the director of the Institute for Cellular Transplantation. He has been heading this research at the UA and developing the implantable device in collaboration with researchers and scientists worldwide.
More here –> Wildcat.Arizona.edu
